Cara Therapeutics | CARA - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Assertio Holdings USD 105.8M 12.5M 2025-09
Cara Therapeutics USD 20.95M 6.92M 2025-12
Cassava Sciences USD 68.14M 6.26M 2026-03
Chugai Pharma JPY 2.03T 135.62B 2025-12
Cipla INR 344.32B 15.13B 2026-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Halozyme Therapeutics USD 219.64M 170.82M 2026-03
J&J USD 81.19B 358M 2026-03
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Pacira USD 653.89M 39.22M 2026-03
Pfizer USD 90.1B 3.63B 2026-03
RedHill Biopharma USD 4.27M 8.68M 2025-12
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12